Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;390(7):691-700.
doi: 10.1007/s00210-017-1370-7. Epub 2017 Mar 30.

The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury

Abdallah M Gendy  1 , Dalaal M Abdallah  2 , Hanan S El-Abhar  3
Affiliations

The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury

Abdallah M Gendy et al. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jul.

Abstract

Rebamipide (Reba), a gastroprotective drug, has signified its hepatoprotective activity; however, its possible post-therapeutic intervention in hepatic ischemia/reperfusion (I/R) remains elusive. Consequently, the intent of this study was to test Reba modulatory effect on nuclear factor (NF)-κB signaling in hepatic I/R model. Rats were randomized into sham, I/R, Reba 60, and Reba100 (60 and 100 mg/kg, respectively) groups. Ischemia was induced for 30 min followed by 3-day reperfusion to set up a model of partial (70%) warm hepatic ischemia. Post-treatment with Reba reduced the serum level of alanine transaminase, improved histopathological alterations of the liver, and elevated hepatic adenosine triphosphate. It also lowered hepatic lipid peroxides and increased both total antioxidant capacity and nitric oxide. Besides, Reba decreased tumor necrosis factor-α, interferon-γ, intercellular adhesion molecule-1, myeloperoxidase, prostaglandin E2, cyclooxygenase-2 expression/content, and caspase-3 activity. Reba also upregulated the gene expression/content of sirtuin 1 (SIRT-1), while it downregulated that of high mobility group box (HMGB)1 and reduced the expression/content of NF-κB p65/pS536-NF-κB and the content of pT180/Y182-p38MAPK. Reba provided tenable hepato-therapeutic mechanisms to mitigate events concomitant with hepatic I/R via inhibition of NF-κB p65 and modulation of its influential signals (SIRT-1, HMGB1, p38MAPK) associated with its antiinflammatory, antioxidant, and antiapoptotic impacts.

Keywords: HMGB1; Hepatic ischemia/reperfusion; NF-κB; Rebamipide; Sirtuin1; p38 MAPK.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Immunol. 2003 Apr 1;170(7):3890-7 - PubMed
    1. J Immunol. 2008 Feb 1;180(3):1843-53 - PubMed
    1. Am J Physiol Cell Physiol. 2006 Dec;291(6):C1318-25 - PubMed
    1. Biochim Biophys Acta. 2011 Dec;1813(12):2165-75 - PubMed
    1. Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14855-60 - PubMed

MeSH terms

LinkOut - more resources